Published in Blood on April 01, 1977
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun (1995) 1.50
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun (1993) 1.11
Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1995) 0.84
Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun (2011) 0.81
Platelets and Platelet Inhibitors in Infective Endocarditis. Curr Infect Dis Rep (2002) 0.81
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med (1970) 4.93
Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med (1992) 4.81
Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med (1998) 4.81
Antibiotic synergism in enterococcal endocarditis. J Lab Clin Med (1976) 3.79
Rat model of experimental endocarditis. Infect Immun (1978) 3.48
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.45
Comparison of two beta-lactamase-producing strains of Streptococcus faecalis. Antimicrob Agents Chemother (1986) 3.33
High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med (1989) 3.02
Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers. Antimicrob Agents Chemother (1980) 2.65
Pharmacology of cefazolin in patients with normal and abnormal renal function. J Infect Dis (1973) 2.49
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis (1981) 2.27
Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin. Antimicrob Agents Chemother (1973) 2.26
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 2.18
beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. J Infect Dis (1987) 2.17
Quantitative bacteriology of the vaginal flora in vaginitis. Am J Obstet Gynecol (1979) 2.02
The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. Am J Gastroenterol (1995) 2.01
The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis (1974) 2.00
Plasma membranes of the rat liver. Isolation and enzymatic characterization of a fraction rich in bile canaliculi. J Cell Biol (1969) 1.95
The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest (1970) 1.91
Quantitative microflora of the vagina. Am J Obstet Gynecol (1977) 1.86
Lack of association between bacteriuria and symptoms in the elderly. Am J Med (1986) 1.85
Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. JAMA (1969) 1.80
Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1972) 1.80
Microbiological agar diffusion assay for metronidazole concentrations in serum. Antimicrob Agents Chemother (1974) 1.70
Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits. Antimicrob Agents Chemother (1977) 1.64
In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8. Antimicrob Agents Chemother (1974) 1.57
In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin. Antimicrob Agents Chemother (1973) 1.51
Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin. Antimicrob Agents Chemother (1978) 1.47
Use of temocillin in typhoid fever, hepatobiliary disease and other infections. Drugs (1985) 1.47
Survey for methicillin-resistant staphylococci. Antimicrob Agents Chemother (1972) 1.43
Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis. Antimicrob Agents Chemother (1981) 1.43
Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits. J Lab Clin Med (1977) 1.42
Cure of Aspergillus ustus endocarditis on a prosthetic valve. Arch Intern Med (1974) 1.41
Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginsoa and Enterobacteriaceae. Infect Immun (1973) 1.41
Manpower in gastroenterology in the United States: a position paper of the Training and Education Committee of the AGA. Gastroenterology (1989) 1.38
Fecal flora in man: effect of cathartic. J Infect Dis (1969) 1.36
Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med (1986) 1.35
Susceptibility to Streptococcus viridans endocarditis in rabbits with intracardiac pacemaker electrodes or polyethylene tubing. J Lab Clin Med (1974) 1.35
Transtracheal aspiration in pulmonary infection. Arch Intern Med (1974) 1.32
The normal human gastric epithelia. A fine structural study. Lab Invest (1968) 1.28
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. J Infect Dis (1986) 1.28
Reduction of biological substances by water-soluble phosphines: gamma-globulin (IgG). Experientia (1969) 1.28
The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever. J Antimicrob Chemother (1981) 1.28
Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest (1976) 1.26
In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic. Antimicrob Agents Chemother (1977) 1.26
Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol (1995) 1.26
In vitro inhibition of growth of neisseria gonorrhoeae by genital microorganisms. Sex Transm Dis (1977) 1.24
Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA (1987) 1.19
Esophageal achalasia probably due to gastric carcinoma. Ann Intern Med (1968) 1.18
Adherence of bacteria to vaginal epithelial cells at various times in the menstrual cycle. Infect Immun (1981) 1.17
Bactericidal activity of ramoplanin against antibiotic-resistant enterococci. Antimicrob Agents Chemother (1992) 1.17
Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation (2000) 1.16
Experimental aspergillus endocarditis in rabbits. J Lab Clin Med (1975) 1.15
Synergistic bactericidal activity of rat serum with vancomycin against enterococci. J Infect Dis (1991) 1.15
Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin Infect Dis (1997) 1.13
New dosing regimens for aminoglycoside antibiotics. Ann Intern Med (1992) 1.12
Single-dose daily gentamicin therapy in urinary tract infection. Antimicrob Agents Chemother (1974) 1.12
Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med (1983) 1.11
Some physiologic properties of heterotopic intestinal epithelium. Its role in transporting lipid into the gastric mucosa. Lab Invest (1967) 1.09
An electron microscopic study of adult celiac disease. Lab Invest (1966) 1.09
Electronystagmography: a review of 17 years experience. Ann Otol Rhinol Laryngol (1975) 1.08
Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis (1997) 1.06
Characteristics of patients with multiple episodes of bacterial endocarditis. JAMA (1970) 1.06
Cefoperazone treatment of experimental endocarditis. Antimicrob Agents Chemother (1981) 1.04
Pharmacology of cefaclor in normal volunteers and patients with renal failure. Antimicrob Agents Chemother (1978) 1.04
Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections. Rev Infect Dis (1985) 1.04
Double-blind comparison of phlebitis produced by cephalothin infusions with buffered and unbuffered diluents. Antimicrob Agents Chemother (1974) 1.03
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole. Antimicrob Agents Chemother (1976) 1.02
In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic. Antimicrob Agents Chemother (1975) 1.01
Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. J Infect Dis (1988) 1.01
Pigment vs cholesterol cholelithiasis: bacteriology of gallbladder stone, bile, and tissue correlated with biliary lipid analysis. Am J Dig Dis (1978) 1.01
HIV testing in Bangkok, Thailand. AIDS (1988) 1.01
Treatment of anaerobic bacterial infections with clindamycin-2-phosphate. Antimicrob Agents Chemother (1974) 1.00
Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother (1989) 1.00
The high frequency of pharyngeal gonococcal infection in a prenatal clinic population. JAMA (1974) 1.00
Comparison of bacterial and fungal adherence to vaginal exfoliated epithelial cells and human vaginal epithelial tissue culture cells. Infect Immun (1982) 1.00
A fine structural characterization of the proliferated endocrine cells in atrophic gastric mucosa. Am J Pathol (1973) 0.99
Degenerative changes in the human vestibular sensory epithelia. Acta Otolaryngol (1975) 0.99
Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1979) 0.97
Penicillin and netilmicin in treatment of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1978) 0.97
Entrance of bacteria into the female urinary bladder. N Engl J Med (1972) 0.97
Antagonism between chloramphenicol and penicillin in streptococcal endocarditis in rabbits. J Lab Clin Med (1975) 0.96
Fibrinogen biosynthesis in isolated guinea pig megakaryocytes. Blood (1985) 0.96
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother (1993) 0.95
Endocrine cells in the normal human stomach. A fine structural study. Gastroenterology (1972) 0.95
Treatment of soft-tissue infection with cephalexin. An orally administered cephalosporin antibiotic. JAMA (1970) 0.95
Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis. Antimicrob Agents Chemother (1983) 0.95
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother (1996) 0.94
Electron microscopic radioautographic identification of the ECL cell as the histamine-synthesizing endocrine cell in the rat stomach. Gastroenterology (1979) 0.93
Tuberculous meningitis in children during the isoniazid era. J Pediatr (1975) 0.93
In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci. Diagn Microbiol Infect Dis (1995) 0.92